🔗 Permalink

Assignee profile:

Crossbeta Biosciences B.V.

City:

Utrecht

Country:

Netherlands

Published Applications:

Last publication date:

2009-08-13

Patent Grants:

Last grant date:

2009-03-03

Top Inventors for applications by Crossbeta Biosciences B.V.

These are the the leading inventors for applications assigned to Crossbeta Biosciences B.V.:

Barend Bouma 7 Houten, Netherlands
Martijn Frans Ben Gerard Gebbink 6 Eemnes, Netherlands
Onno Wouter Kranenburg 2 Amsterdam, Netherlands
Johan Renes 2 Amersfoort, Netherlands

Paulus Johannes Gerardus Maria Steverink 2 Huizen, Netherlands
Manuel Castro Cabezas 1 Zeist, Netherlands
Louise M. J. Kroon-Batenburg 1 Bunnik, Netherlands
Martijn Frans Ben Gerard Gebbink Bunnik 1 Bunnik, Netherlands

Herman Abel Bernard Wösten 1 Zeist, Netherlands
Louise Maria Johanna Kroon 1 Bunnik, Netherlands
Emile Eugene Voest 1 Soest, Netherlands
Martin F. B. G. Gebbink 1 Eemnes, Netherlands

Onno W. Kranenburg 1 Amsterdam, Netherlands
Hans van Dijk 1 De Bilt, Netherlands
Martijn Frans, B.G. Gebbink 1 Eemnes, Netherlands
Louise Maria Johanna Kroon-Batenburg 1 Eemnes, Netherlands

Recent patent applications by Crossbeta Biosciences B.V.

Crossbeta Biosciences B.V. based in Utrecht, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2009-08-13

US20090202980A1

Chemistry; metallurgy

Cross-Beta Structure Comprising Amyloid Binding Proteins and Methods for Detection of the Cross-Beta Structure, for Modulating Cross-Beta Structures Fibril Formation and for Modulating Cross-Beta Structure-Mediated Toxicity and Method for Interfering With Blood Coagulation

#2 | 2009-07-30

US20090191228A1

Chemistry; metallurgy

Immunogenic compositions capable of activating T-cells

#3 | 2009-06-04

US20090142377A1

Human necessities

Immunogenic compositions

#4 | 2009-03-03 ✅ Patent 7,498,147 granted on 2009-03-03

US10327604

Diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases

#5 | 2008-10-30 ✅ Patent 8,067,187 granted on 2011-11-29

US20080267948A1

Physics

Cross-β structure binding compounds

#6 | 2008-10-02 ✅ Patent 8,158,585 granted on 2012-04-17

US20080241165A1

Human necessities

Cross-β structure comprising amyloid-binding proteins and methods for detection of the cross-β structure, for modulating cross-β structures fiber formation and modulating cross-β structure-mediated toxicity

#7 | 2007-01-18 ✅ Patent 8,114,832 granted on 2012-02-14

US20070015206A1

Physics

Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition

#8 | 2006-12-28

US20060292683A1

Chemistry; metallurgy

Cross-beta structures on microbial organisms

#9 | 2006-11-30

US20060270599A1

Chemistry; metallurgy

Inhibiting angiogenesis using molecules that enhance plasmin formation or prolong plasmin activity

AssigneeID:

248563 ⎘